# Enliven Therapeutics, Inc. (ELVN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/elvn for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Enliven Therapeutics, Inc. is a biopharmaceutical enterprise, currently in the clinical development phase, dedicated to discovering and advancing small molecule therapeutic agents aimed at combating cancer. Its pipeline includes ELVN-001, a small molecule kinase inhibitor currently in a Phase 1 clinical trial for adult patients with chronic myeloid leukemia. Another key candidate, ELVN-002, also a small molecule kinase inhibitor, has begun a Phase 1 clinical assessment for individuals with cancers exhibiting an abnormal HER2 gene. The company's base of operations is located in Boulder, Colo...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $41.52 USD |
| Market Cap | $3.04B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.67 |
| 52-Week Range | $14.79 – $62.32 |
| Dividend Yield (TTM) | — |

## Dividend

ELVN has no dividend payment history in our records.

## Frequently Asked Questions

### What does Enliven Therapeutics, Inc. do?

Enliven Therapeutics, Inc. (ELVN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ELVN's market cap?

Enliven Therapeutics, Inc. (ELVN) has a market capitalization of approximately $3.04 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does ELVN pay a dividend?

No, Enliven Therapeutics, Inc. (ELVN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ELVN profitable?

Enliven Therapeutics, Inc. (ELVN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ELVN ever paid a dividend?

No. Dividend Data's records show no dividend payments from Enliven Therapeutics, Inc. (ELVN). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/elvn
- Dividend history & safety: https://www.dividenddata.com/stocks/elvn/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/elvn/earnings
- Financial statements: https://www.dividenddata.com/stocks/elvn/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/elvn/valuation
- Peer comparison: https://www.dividenddata.com/stocks/elvn/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.